Nextgen Healthcare Valuation

Nextgen Healthcare Investor Information

About 34.0% of the company outstanding shares are owned by corporate insiders. The book value of Nextgen Healthcare was now reported as 6.31. The company has Price/Earnings To Growth (PEG) ratio of 2.56. Nextgen Healthcare recorded a loss per share of 0.09. The entity last dividend was issued on the 9th of December 2015. The firm had 2:1 split on the 27th of October 2011. Based on the measurements of operating efficiency obtained from Nextgen Healthcare's historical financial statements, Nextgen Healthcare is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.

Nextgen Healthcare Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Nextgen Healthcare has an asset utilization ratio of 72.89 percent. This suggests that the Company is making $0.73 for each dollar of assets. An increasing asset utilization means that Nextgen Healthcare is more efficient with each dollar of assets it utilizes for everyday operations.

Nextgen Healthcare Ownership Allocation

Nextgen Healthcare maintains a total of 67.1 Million outstanding shares. The majority of Nextgen Healthcare outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Nextgen Healthcare to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Nextgen Healthcare. Please pay attention to any change in the institutional holdings of Nextgen Healthcare as this could imply that something significant has changed or is about to change at the company. Also note that almost ten million fifty-one thousand one hundred sixteen invesors are currently shorting Nextgen Healthcare expressing very little confidence in its future performance.

Nextgen Healthcare Profitability Analysis

The company reported the previous year's revenue of 653.17 M. Net Loss for the year was (2.65 M) with profit before overhead, payroll, taxes, and interest of 332.83 M.

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

If you are still planning to invest in Nextgen Healthcare check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nextgen Healthcare's history and understand the potential risks before investing.